DekaBank Deutsche Girozentrale
VTYX

DekaBank Deutsche Girozentrale’s Ventyx Biosciences VTYX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,000
Closed -$529K – 1530
2023
Q3 		$529K Hold
15,000
– – ﹤0.01% 1006
2023
Q2 		$477K Hold
15,000
– – ﹤0.01% 1035
2023
Q1 		$505K Hold
15,000
– – ﹤0.01% 1006
2022
Q4 		$494K Hold
15,000
– – ﹤0.01% 1038
2022
Q3 		$532K Buy
+15,000
New +$332K ﹤0.01% 1031

Other funds holding VTYX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

DekaBank Deutsche Girozentrale's VTYX Position: Q4 2023 in Review

DekaBank Deutsche Girozentrale sold out of Ventyx Biosciences (VTYX) in Q4 2023, closing a stake of 15,000 shares — an estimated $529K sold.

DekaBank Deutsche Girozentrale first reported a position in VTYX in Q3 2022 and held it in 5 quarters. The position peaked at $532K in Q3 2022. 121 funds tracked by Wall St. Rank hold VTYX as of Q4 2023.

  • DekaBank Deutsche Girozentrale reported no remaining Ventyx Biosciences position as of Q4 2023 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 15,000 Ventyx Biosciences shares in Q4 2023, an estimated $529K.
  • DekaBank Deutsche Girozentrale first reported a position in Ventyx Biosciences in Q3 2022 and held it in 5 quarters.
  • DekaBank Deutsche Girozentrale's Ventyx Biosciences position peaked at $532K in Q3 2022.
  • 121 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2023, filed 24 Jan 2024.